IQVIA Holdings Inc.’s Stock Price Dips to $141.82, Reflecting a 5.88% Decline: A Critical Market Performance Review

IQVIA Holdings Inc. (IQV)

141.82 USD -8.86 (-5.88%) Volume: 2.74M

IQVIA Holdings Inc.’s stock price is currently at 141.82 USD, experiencing a decrease of -5.88% this trading session with a trading volume of 2.74M, reflecting an overall YTD percentage change of -27.83%, highlighting a significant movement in the healthcare sector’s performance.

Latest developments on IQVIA Holdings Inc.

IQVIA Holdings Inc. stock experienced underperformance on Wednesday in comparison to its competitors. Despite this, there is a positive outlook for the company driven by resilient TAS, strategic capital allocation, and R&D strength. The recent Q1 2025 earnings call transcript for IQVIA Holdings Inc. (NYSE:IQV) has also been promising. Investors considering investing in IQVIA should not overlook assessing its international revenue trends as well.

A look at IQVIA Holdings Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

IQVIA Holdings Inc. has a mixed outlook according to Smartkarma Smart Scores. While the company scores moderately in Value, Growth, Resilience, and Momentum, it falls short in the Dividend category. This suggests that investors may find potential in the company’s overall performance and stability, but may not expect significant returns in terms of dividends.

IQVIA Holdings Inc. focuses on technology solutions and contract research services for various industries globally. With a balanced rating across key factors such as Growth, Resilience, and Momentum, the company appears to be well-positioned for long-term success. However, the lower score in the Dividend category may be a point of consideration for investors seeking consistent income from their investments.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma